You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

immuno-oncology

Showing 1 - 25 of 2,608
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastroesophageal Adenocarcinoma Trial (toripalimab FOLFOX)

Not yet recruiting
  • Gastroesophageal Adenocarcinoma
  • toripalimab FOLFOX
  • (no location specified)
Aug 3, 2023

Kidney Cancer, Clear Cell Renal Cell Carcinoma Metastatic, Synchronous Tumor Trial in Seoul (Cytoreductive

Recruiting
  • Kidney Cancer
  • +2 more
  • Cytoreductive nephrectomy±metastasectomy
  • Human-derived materials sampling
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Mar 2, 2023

NSCLC Patients Trial in Marseille (procedure, diagnostic test, other)

Recruiting
  • Non-small Cell Lung Cancer Patients
  • BIOPSY
  • +2 more
  • Marseille, France
    Assistance Pubique Hopitaux de Marseille
Sep 21, 2022

NSCLC Trial in Marseille (Durvalumab (MEDI4736), Monalizumab (IPH2201), Oleclumab (MEDI9447))

Recruiting
  • Non-small Cell Lung Cancer
  • Durvalumab (MEDI4736)
  • +5 more
  • Marseille, France
    Assistance Publique Hopitaux de Marseille
Sep 21, 2022

Biospecimen Procurement for Center for Immuno-Oncology

Recruiting
  • Multiple Myeloma
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jul 13, 2022

    Circulating Tumor DNA Kinetics in Immuno-oncology

    Completed
    • Head and Neck Cancer
    • +4 more
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      May 16, 2022

      Solid Tumor Trial in Beijing (GLS-012, GLS-010)

      Recruiting
      • Solid Tumor
      • Beijing, China
        Beijing Cancer Hospital
      Jun 11, 2023

      Inflammatory Arthritis, Immune-related Adverse Event Trial (Adalimumab, Prednisone)

      Not yet recruiting
      • Inflammatory Arthritis
      • Immune-related Adverse Event
      • (no location specified)
      Sep 13, 2023

      Renal Cell Carcinoma Trial in Amsterdam, London (Neoadjuvant nivolumab, Neoadjuvant ipilimumab, Neoadjuvant relatlimab)

      Recruiting
      • Renal Cell Carcinoma
      • Neoadjuvant nivolumab
      • +2 more
      • Amsterdam, NH, Netherlands
      • +1 more
      May 3, 2022

      Malignancy, Immune System Diseases, Autoimmune Diseases Trial in Chapel Hill (Biospecimen Collection, Medical Chart Review,

      Recruiting
      • Malignancy
      • +2 more
      • Biospecimen Collection
      • +2 more
      • Chapel Hill, North Carolina
        Lineberger Comprehensive Cancer Center at University of North Ca
      Feb 11, 2022

      Multiple Myeloma Trial in Miami (Teclistamab, Talquetamab, Daratumumab SC)

      Not yet recruiting
      • Multiple Myeloma
      • Miami, Florida
        University of Miami
      Oct 20, 2023

      Renal Cell Carcinoma, Metastatic Castration-resistant Prostate Cancer, Urothelial Carcinoma Trial in United States (XL092,

      Recruiting
      • Renal Cell Carcinoma
      • +3 more
      • Tucson, Arizona
      • +3 more
      Mar 30, 2022

      Cancer Trial in Dallas

      Recruiting
      • Cancer
        • Dallas, Texas
          Baylor Scott & White Research Institute
        May 11, 2022

        Cabozantinib Post First-line Immuno-oncology Checkpoint

        Completed
        • Advanced Renal Cell Carcinoma (aRCC)
          • Glasgow, United Kingdom
          • +8 more
          Jun 30, 2022

          Learn About First and Later Lines of Medicines in Treating

          Completed
          • Metastatic Renal Cell Carcinoma
            • New York, New York
              Pfizer Headquarters
            May 12, 2023

            Locally Advanced Pancreatic Adenocarcinoma Trial in Houston (SD-101, pebrolizumab)

            Recruiting
            • Locally Advanced Pancreatic Adenocarcinoma
            • Houston, Texas
              MD Anderson Cancer Center
            Nov 18, 2022

            Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma Trial in Houston (SD-101, Pembrolizumab, Nivolumab)

            Recruiting
            • Hepatocellular Carcinoma
            • Intrahepatic Cholangiocarcinoma
            • New York, New York
            • +3 more
            Oct 19, 2022

            Urine Omics Predicting IO Therapy Responses in mRCC Patients

            Recruiting
            • Metastatic Renal Cell Carcinoma
            • No intervention required
            • Taipei, Taiwan
              National Taiwan University Hospital
            Jan 18, 2022

            Metastatic Uveal Melanoma in the Liver Trial in United States (SD-101, Nivolumab, Ipilimumab)

            Recruiting
            • Metastatic Uveal Melanoma in the Liver
            • Los Angeles, California
            • +9 more
            Jan 27, 2023

            Cancer Trial in Chicago (Nivolumab, Cabiralizumab, Urelumab)

            Active, not recruiting
            • Cancer
            • Chicago, Illinois
              University of Chicago Medical Center
            Mar 14, 2022

            Urine Omics Predicting IO Therapy Responses in mUC Patients

            Recruiting
            • Metastatic Urothelial Carcinoma
            • No intervention required
            • Taipei, Taiwan
              National Taiwan University Hospital
            Dec 19, 2021

            Melanoma Trial in Bordeaux, Toulouse (Dedicated and coordinated e-follow-up during the treatment period, Standard follow-up

            Completed
            • Melanoma
            • Dedicated and coordinated e-follow-up during the treatment period
            • Standard follow-up during the treatment period
            • Bordeaux, France
            • +1 more
            Feb 23, 2021

            Learn More About How WellTreatment Works When Given After

            Not yet recruiting
            • Unresectable Hepatocellular Carcinoma
            • Baltimore, Maryland
            • +19 more
            Oct 31, 2023

            Solid Tumor, Adult Trial in United States (IMSA101, Immune checkpoint inhibitor (ICI), Immuno-oncology (IO) therapy)

            Recruiting
            • Solid Tumor, Adult
            • Scottsdale, Arizona
            • +5 more
            Apr 14, 2022

            Carcinoma, Renal Cell Trial in Worldwide (DFF332, RAD001, PDR001)

            Recruiting
            • Carcinoma, Renal Cell
            • Duarte, California
            • +10 more
            Jun 13, 2022